Resource Logo

The prevalence of high risk sexual behavior in male heterosexual IV drug users.


Int Conf AIDS. 1989 Jun 4-9;5:709 (abstract no. Th.D.0.14). Unique

OBJECTIVE: To determine the prevalence of high risk sexual behavior in male intravenous drug users (IVDUs) with regular female sexual partners. METHODS: One hundred forty-nine IVDUs (70 whites and 79 blacks) with stable partners were interviewed in early 1987. RESULTS: During the previous year, 63% had more than 1 female partner and 31% had 4 or more female partners. The median number of female sexual partners was 3 for whites and 2 for blacks. Eleven percent (16/149) had sexual contact with males, with no significant difference between whites and blacks (7% or 5/70 vs. 14% or 11/79, respectively, P=.14). Heterosexual anal intercourse was reported by 38% (56/149), with whites more likely than blacks to report this behavior, i.e. 46% (32/70) vs. 30% (24/79) respectively (P=.04). Reports of never using condoms were given by 73% (108/148), a proportion similar for the 2 groups of men. Of the 128 men who reported whether their steady female partners injected drugs, 40% (51/128) said their partners were not IVDUs. Blacks were more likely than whites to have non-drug injecting sexual partners, i.e. 54% (37/68) vs. 23% (14/60) (P less than .001). Blacks were also more likely than whites to report no enrollment in drug treatment programs during the previous 5 years, i.e. 49% (39/79) vs. 20% (14/70) (P less than .01). CONCLUSION: This study demonstrates that educational outreach programs in sexual risk reduction are urgently needed for both IVDUs and their sexual partners. The need for culturally relevant programs is particularly important for black IVDUs and their sexual partners in San Francisco.

Blacks/*PSYCHOLOGY Contraceptive Devices, Male/UTILIZATION Human Male Prevalence Risk Factors San Francisco/EPIDEMIOLOGY *Sex Behavior Sex Education Sexual Partners/PSYCHOLOGY Substance Dependence/*EPIDEMIOLOGY Whites/PSYCHOLOGY ABSTRACT


Information in this article was accurate in September 30, 1990. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.